HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Aaron I Vinik Selected Research

NAD (NADH)

2/2015A pooled analysis evaluating the efficacy and tolerability of tapentadol extended release for chronic, painful diabetic peripheral neuropathy.
8/2014A randomized withdrawal, placebo-controlled study evaluating the efficacy and tolerability of tapentadol extended release in patients with chronic painful diabetic peripheral neuropathy.
2/2013Contact heat-evoked potential stimulation for the evaluation of small nerve fiber function.
11/2008German-translated Norfolk quality of life (QOL-DN) identifies the same factors as the English version of the tool and discriminates different levels of neuropathy severity.
4/2007A 6-month, randomized, double-masked, placebo-controlled study evaluating the effects of the protein kinase C-beta inhibitor ruboxistaurin on skin microvascular blood flow and other measures of diabetic peripheral neuropathy.
12/2006Diabetic nerve conduction abnormalities in the primary care setting.
5/2006Pathophysiology and treatment of diabetic peripheral neuropathy: the case for diabetic neurovascular function as an essential component.
11/2005Sural sensory action potential identifies diabetic peripheral neuropathy responders to therapy.
9/2005Safety and effectiveness of topiramate for the management of painful diabetic peripheral neuropathy in an open-label extension study.
8/2005Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Aaron I Vinik Research Topics

Disease

13Neoplasms (Cancer)
02/2016 - 11/2005
13Neuroendocrine Tumors (Neuroendocrine Tumor)
02/2016 - 11/2005
13Peripheral Nervous System Diseases (PNS Diseases)
07/2015 - 12/2004
6Diabetic Neuropathies (Diabetic Neuropathy)
01/2013 - 05/2006
6Hyperglycemia
11/2012 - 11/2004
5Pain (Aches)
02/2015 - 09/2005
5Diabetes Mellitus
01/2014 - 12/2004
4Carcinoid Tumor (Carcinoid)
05/2015 - 11/2005
4Neoplasm Metastasis (Metastasis)
05/2015 - 09/2009
4Polyneuropathies (Polyneuropathy)
03/2015 - 01/2004
3Neuralgia (Stump Neuralgia)
02/2015 - 09/2007
3Type 2 Diabetes Mellitus (MODY)
11/2012 - 09/2003
3Body Weight (Weight, Body)
10/2010 - 09/2005
3Insulin Resistance
09/2005 - 06/2003
2Gangrene
07/2015 - 09/2007
2Hypesthesia (Numbness)
03/2015 - 09/2007
2Primitive Neuroectodermal Tumors (PNET)
11/2014 - 09/2013
2Nausea
08/2014 - 09/2005
2Insulinoma
09/2013 - 09/2009
2Flushing
03/2013 - 10/2011
2Paraganglioma (Paragangliomas)
03/2013 - 08/2010
2Carcinoid Heart Disease
10/2011 - 11/2009
2Diarrhea
10/2011 - 09/2005
2Obesity
01/2010 - 03/2005
2Ischemia
01/2010 - 04/2006
2Dyslipidemias (Dyslipidemia)
01/2010 - 01/2005
2Ataxia (Dyssynergia)
01/2008 - 09/2007
2Headache (Headaches)
03/2007 - 09/2005
2Weight Loss (Weight Reduction)
09/2005 - 03/2005
1Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
03/2015
1Vomiting
08/2014
1Familial Amyloid Neuropathies (Familial Amyloid Polyneuropathy)
06/2014
1Gastrinoma
09/2013
1Prediabetic State (Prediabetes)
08/2013
1Vipoma (WDHA)
03/2013
1Acromegaly
09/2010
1Pheochromocytoma
08/2010
1Hypoglycemia (Reactive Hypoglycemia)
09/2009

Drug/Important Bio-Agent (IBA)

11NAD (NADH)IBA
02/2015 - 12/2004
9Glucose (Dextrose)FDA LinkGeneric
01/2014 - 05/2003
6Biological Markers (Surrogate Marker)IBA
02/2016 - 11/2009
5Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
05/2015 - 08/2010
4Sirolimus (Rapamycin)FDA Link
05/2015 - 09/2009
4Octreotide (Sandostatin)FDA LinkGeneric
10/2011 - 11/2005
3PeptidesIBA
02/2016 - 03/2011
3HormonesIBA
09/2013 - 05/2003
3Streptozocin (Streptozotocin)FDA Link
03/2011 - 11/2004
3AntibodiesIBA
07/2010 - 01/2008
3topiramate (Topamax)FDA LinkGeneric
01/2010 - 09/2005
3Insulin (Novolin)FDA Link
01/2010 - 01/2005
3protein kinase C betaIBA
04/2007 - 08/2005
3HDL CholesterolIBA
09/2005 - 06/2003
2Neurokinin AIBA
05/2015 - 10/2011
2Chromogranin AIBA
05/2015 - 10/2006
2Hydroxyindoleacetic AcidIBA
05/2015 - 04/2013
2Immunoglobulins (Immunoglobulin)IBA
03/2015 - 01/2008
23- (3- dimethylamino- 1- ethyl- 2- methylpropyl)phenolFDA Link
02/2015 - 08/2014
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
11/2014 - 09/2013
2sunitinib (Sutent)FDA Link
09/2013 - 03/2013
2Acetylcholine (Acetylcholine Chloride)FDA Link
08/2013 - 08/2008
2Lipoproteins (Lipoprotein)IBA
03/2013 - 01/2005
2pregabalin (Lyrica)FDA Link
01/2013 - 09/2007
2ruboxistaurinIBA
04/2007 - 08/2005
2rosiglitazone (Avandia)FDA Link
04/2007 - 09/2003
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
12/2006 - 03/2003
1Peroxynitrous Acid (Peroxynitrite)IBA
07/2015
1Phosphopyruvate Hydratase (Enolase)IBA
05/2015
1Peptide Receptors (Peptide Receptor)IBA
05/2015
1Somatostatin Receptors (Somatostatin Receptor)IBA
05/2015
1Intravenous Immunoglobulins (IVIG)FDA Link
03/2015
1Acetic Acid (Vinegar)FDA LinkGeneric
11/2014
1Prealbumin (Transthyretin)IBA
06/2014
1everolimusFDA Link
09/2013
1Interleukin-8 (Interleukin 8)IBA
09/2013
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
09/2013
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
03/2013
1Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA
03/2013
1Niacin (Nicotinic Acid)FDA LinkGeneric
03/2013
1Prostaglandin D2IBA
03/2013
1Prostaglandins D (PGD)IBA
03/2013
1APTIBA
01/2013
1Bromocriptine (Parlodel)FDA LinkGeneric
11/2012
1Metformin (Glucophage)FDA LinkGeneric
11/2012
1ThiazolidinedionesIBA
11/2012
1Thioctic Acid (Lipoic Acid)IBA
09/2011
1AminesIBA
03/2011
1Growth Hormone (Somatotropin)IBA
09/2010
1Insulin-Like Growth Factor I (IGF-1)IBA
09/2010
1medullary Thyroid cancerIBA
08/2010
1CatecholaminesIBA
08/2010
1pancreastatinIBA
07/2010
1rosuvastatin (Crestor)FDA Link
01/2010
1Phenytoin (Dilantin)FDA LinkGeneric
09/2009

Therapy/Procedure

4Amputation
07/2015 - 03/2003
3Lasers (Laser)
08/2013 - 04/2006
1Radiotherapy
05/2015
1Cholecystectomy
05/2015
1Immunotherapy
03/2015
1Oral Administration
03/2013
1Anesthesia
08/2010